In Group D, we included 5 patients (male/female: 1/4; median age at diagnosis: 19.0; range: 7–44) who had an initial diagnosis of CVID, but genetic analysis revealed the presence of pathogenic CTLA4 mutations. The gene discussed is CTLA4; the disease is common variable immunodeficiency.